Peptide Drugs advanced
Survodutide: Oligopeptide Research Reference
Dual glucagon/GLP-1 receptor agonist for obesity and metabolic dysfunction-associated steatohepatitis. This peptide or oligopeptide is studied for its biolog...
By Encyclopeptide Editorial | 1 min read
glp1 dual-agonist obesity
Overview
Dual glucagon/GLP-1 receptor agonist for obesity and metabolic dysfunction-associated steatohepatitis.
Structure
| Property | Value |
|---|---|
| Name | Survodutide |
Mechanism of Action
Glucagon receptor activation adds hepatic lipid mobilization to GLP-1 metabolic benefits.
References
- Wikipept Peptide Database
- Primary literature (see individual entries)
Chemical Identity
| Property | Value |
|---|---|
| Name | Survodutide |
| Category | Peptide Drugs |
Test Your Knowledge
Reinforce what you learned about Survodutide: Oligopeptide Research Reference with interactive quizzes on Wikipept.
Take a Quiz on Wikipept